[1]
V. VERMA, H. RN, S. S. BASRA, N. CHOUREY, and P. SINHA, “PROFILE OF SURROGATE MARKERS OF MOLECULAR SUBTYPES USING THE EXPRESSION PATTERN OF ER, PR, AND HER2/NEU RECEPTORS IN OPERABLE BREAST CANCER”, Asian J Pharm Clin Res, vol. 14, no. 9, pp. 149–152, Sep. 2021.